Medtronic plc (MDT) operating KPIs

MDTNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends April 24

Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026Score 19/303% below fair value

$96.54−0.57 (-0.59%)

Close on Oct 30, 2026Market cap $123.49BP/E 23.7Yield 2.94%

Medtronic fDA Premarket Approvals (PMA & Supplements) — U.S. Industry Total

Quarterly figures from Medtronic's filings and investor materials

Quarterly Annual Monthly

Latest, Q1 FY27

616

Period ended Jul 31, 2026

Change on a year earlier

+3.2%

597 in Q1 FY26

History

51 quarters

Since Q3 FY14

Sources

U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

Period	Ended	FDA Premarket Approvals (PMA & Supplements) — U.S. Industry Total	Year on year	Source
Q1 FY27	Jul 31, 2026	616	+3.2%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY26	Apr 30, 2026	641	+13.7%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY26	Jan 31, 2026	434	-28.5%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY26	Oct 31, 2025	613	+7.7%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q1 FY26	Jul 31, 2025	597	+3.8%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY25	Apr 30, 2025	564	+16.0%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY25	Jan 31, 2025	607	+4.3%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY25	Oct 31, 2024	569	-5.2%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q1 FY25	Jul 31, 2024	575	+1.1%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY24	Apr 30, 2024	486	+6.6%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY24	Jan 31, 2024	582	+7.2%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY24	Oct 31, 2023	600	+25.3%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q1 FY24	Jul 31, 2023	569	+15.4%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY23	Apr 30, 2023	456	-15.9%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY23	Jan 31, 2023	543	-4.4%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY23	Oct 31, 2022	479	-11.5%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q1 FY23	Jul 31, 2022	493	-7.3%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY22	Apr 30, 2022	542	-10.6%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY22	Jan 31, 2022	568	-7.5%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY22	Oct 31, 2021	541	-18.0%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q1 FY22	Jul 31, 2021	532	-12.6%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY21	Apr 30, 2021	606	+2.9%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY21	Jan 31, 2021	614	+3.5%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY21	Oct 31, 2020	660	+3.9%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q1 FY21	Jul 31, 2020	609	-20.8%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY20	Apr 30, 2020	589	-7.7%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY20	Jan 31, 2020	593	-3.1%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY20	Oct 31, 2019	635	+3.1%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q1 FY20	Jul 31, 2019	769	+0.9%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY19	Apr 30, 2019	638	-18.9%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY19	Jan 31, 2019	612	-8.9%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY19	Oct 31, 2018	616	-16.9%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q1 FY19	Jul 31, 2018	762	+6.4%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY18	Apr 30, 2018	787	+28.0%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY18	Jan 31, 2018	672	+16.7%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY18	Oct 31, 2017	741	+5.9%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q1 FY18	Jul 31, 2017	716	+21.2%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY17	Apr 30, 2017	615	-8.8%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY17	Jan 31, 2017	576	+10.3%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY17	Oct 31, 2016	700	+43.1%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q1 FY17	Jul 31, 2016	591	+5.2%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY16	Apr 30, 2016	674	+9.8%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY16	Jan 31, 2016	522	+9.7%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY16	Oct 31, 2015	489	-25.8%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q1 FY16	Jul 31, 2015	562	-18.0%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY15	Apr 30, 2015	614	-2.5%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY15	Jan 31, 2015	476	+175.1%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY15	Oct 31, 2014	659	–	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q1 FY15	Jul 31, 2014	685	–	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY14	Apr 30, 2014	630	–	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY14	Jan 31, 2014	173	–	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗

Cite this data

StockData. (2026). Medtronic FDA Premarket Approvals (PMA & Supplements) — U.S. Industry Total, quarterly Q3 FY14–Q1 FY27 [Data set]. Compiled from Medtronic SEC filings and investor materials. https://stockdatahq.com/stocks/mdt/kpis/ext-fda-pma-ind

See every metric in the Medtronic KPI table. Data updated Oct 31, 2026.